COVID-19 ‘vaccine’ drugs are modified mRNA gene therapy products. So, why did the FDA assign the review and recommendation responsibilities to the Vaccines and Related Biological Products Committee (VRBPAC) instead of the Cellular Tissue and Gene Therapy Advisory Committee (CTGTAC)? CTGTAC was the logical FDA advisory committee for such a […]
Report 96: mRNA COVID-19 Shots – ‘Vaccines’ or Gene Therapy Products? – Part 2
When considering a drug for emergency use authorization (EUA), the Food and Drug Administration (FDA) selects an internal advisory committee to review information and data submitted to the FDA by the pharmaceutical company about its new drug. These influential FDA advisory committees, based on that information and data, make recommendations […]